SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Read more breaking news

 

 
News in brief

LabCorp in talks to buy PPD for $8Bn

By Dani Bancroft

06-Feb-2017
Last updated on 06-Feb-2017 at 17:28 GMT2017-02-06T17:28:13Z

LabCorp in talks to buy the CRO PPD for $8Bn

Unconfirmed reports suggest Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract research organization Pharmaceutical Product Development LLC (PPD).

According to a Reuters report , a second party is taking part in the auction of PPD with LabCorp, but has not yet been identified

If LabCorp was to acquire PPD, the transaction's value would exceed the $5.7bn for which it purchased Covance  in 2015.

PPD offers contract research services from inhalation products to biologics , for a wide range of indications, with headquarters in Wilmington, North Carolina. 

The firm has more than 18,500 employees worldwide and is owned by Carlyle Group LP and Hellman & Friedman LLC, which made the company private in 2011 for $3.9bn.

LabCorp is a North Carolina, US-based clinical lab network with a $14.3bn (€13.3bn) market cap. Last month, it acquired  Mount Sinai’s clinical outreach laboratories, adding seven patient service centers to its network.

Related products

Related suppliers

Key Industry Events